Relevant prognostic predictors of sarcoidosis course Source: Eur Respir J 2001; 18: Suppl. 33, 345s Year: 2001
Sarcoidosis: Clinical course and prognostic predictors Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010
Predicting the course of sarcoidosis with clinical factors Source: Eur Respir J 2005; 26: Suppl. 49, 32s Year: 2005
Prognostic significance of Glasgow Prognostic Score in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017
Outcome predictive factors in patients with sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017
Predictive value of clinical diagnosis in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 345s Year: 2001
Prognostic evaluation of COPD patients with pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005
Prognostic predictors for survival in patients with COPD using cardiopulmonary testing Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002
Prognostic features of disability in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 57s Year: 2004
Prognostic values of biomarkers in COPD Source: Annual Congress 2013 –Natural history of COPD: novel aspects Year: 2013
Clinical features and prognostic factors in elderly patients with aspiration pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012
Prognostic significance of clinical and morphological features in idiopathic interstitial pneumonias Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002
Prognostic predictors of survival in patients with COPD hospitalized for an acute exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Prognostic determinants in IPF patients with the histological features of usual interstitial pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 526s Year: 2001
Prognostic factors in patients with EAA Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019
Therapeutic outcome and prognostic factors in patients with pleural mesothelioma Source: Eur Respir J 2005; 26: Suppl. 49, 73s Year: 2005
Is YKL-40 a prognostic marker in sarcoidosis? Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Prognostic value of two clinical scores in patients with acute symptomatic pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011
Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006